C12Q   1/00  \	0	0	4B063	C12Q   1/00	577	ǡ˻ޤʪޤ¬ޤϻˡʾ֤¬ޤϸмʤ¬ޤϻ֡㡥ˡ׿ãͣˡΤʪΤ褦ʪ¤ˡΣ	Measuring or testing processes involving enzymes, nucleic acids or microorganisms (measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34); Compositions therefor; Processes of preparing such compositions [3]
C12Q   1/00  B	0	0	4B063	C12Q   1/00	479	ŶˤѤ	Using enzyme electrodes
C12Q   1/00  C	0	0	4B063	C12Q   1/00	807	경줿ǡʪ	Fixed enzyme/microorganism specimen
C12Q   1/00  Z	0	0	4B063	C12Q   1/00	870	¾㡥ιǤǤϤʤ	Others ( not a specific enzyme)
C12Q   1/02  \	1	1	4B063	C12Q   1/02	20915	ʪޤΡΣ	involving viable micro-organisms [3]
C12Q   1/04  \	2	2	4B063	C12Q   1/04	7165	ʪ¸ߤޤϼηꡨʪޤϻٶݺޤλΤϤλѡΤβػؼޤʪΣ	Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor [3]
C12Q   1/06  \	3	3	4B063	C12Q   1/06	3371	Ū¬Σ	Quantitative determination [3]
C12Q   1/08  \	4	4	4B063	C12Q   1/08	52	¿եɤϤѤΡΣ	using multifield media [3]
C12Q   1/10  \	3	3	4B063	C12Q   1/10	168	ƥХƥꥢΣ	Enterobacteria [3]
C12Q   1/12  \	3	3	4B063	C12Q   1/12	42	˻򰡾˻˴ĸٶݤޤϥʥꥢΣ	Nitrate to nitrite reducing bacteria [3]
C12Q   1/14  \	3	3	4B063	C12Q   1/14	171	ȥץȥåեåΣ	Streptococcus; Staphylococcus [3]
C12Q   1/16  \	3	3	4B063	C12Q   1/16	39	ʪѤΡΣ	using radioactive material [3]
C12Q   1/18  \	2	2	4B063	C12Q   1/18	546	ʪιݳλΣ	Testing for antimicrobial activity of a material [3]
C12Q   1/20  \	3	3	4B063	C12Q   1/20	24	¿եɤϤѤΡΣ	using multifield media [3]
C12Q   1/22  \	2	2	4B063	C12Q   1/22	140	̵ݾ֤ΤλΣ	Testing for sterility conditions [3]
C12Q   1/24  \	2	2	4B063	C12Q   1/24	518	μ衤ܼޤۤˡʪʪŪʬΥˡΣ	Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact micro-organism [3]
C12Q   1/25  \	1	1	4B063	C12Q   1/25	917	롼ףãѣãѣʬǤʤǤޤΡΣ	involving enzymes not classifiable in groups C12Q 1/26-C12Q 1/70 [5]
C12Q   1/26  \	1	1	4B063	C12Q   1/26	3187	ԸǤޤΡΣ	involving oxidoreductase [3]
C12Q   1/28  \	2	2	4B063	C12Q   1/28	1545	ѡޤΡΣ	involving peroxidase [3]
C12Q   1/30  \	2	2	4B063	C12Q   1/30	201	顼ޤΡΣ	involving catalase [3]
C12Q   1/32  \	2	2	4B063	C12Q   1/32	1562	ǥҥɥʡޤΡΣ	involving dehydrogenase [3]
C12Q   1/34  \	1	1	4B063	C12Q   1/34	2392	ÿʬǤޤΡΣ	involving hydrolase [3]
C12Q   1/37  \	2	2	4B063	C12Q   1/37	2785	ڥץޤϥץƥʡޤΡΣ	involving peptidase or proteinase [5]
C12Q   1/40  \	2	2	4B063	C12Q   1/40	473	ߥ顼ޤΡΣ	involving amylase [3]
C12Q   1/42  \	2	2	4B063	C12Q   1/42	1197	ۥեޤΡΣ	involving phosphatase [3]
C12Q   1/44  \	2	2	4B063	C12Q   1/44	1232	ƥ顼ޤΡΣ	involving esterase [3]
C12Q   1/46  \	3	3	4B063	C12Q   1/46	124	󥨥ƥ顼ޤΡΣ	involving cholinesterase [3]
C12Q   1/48  \	1	1	4B063	C12Q   1/48	585	žܹǤޤΡΣ	involving transferase [3]
C12Q   1/48  A	1	0	4B063	C12Q   1/48	148	áݥ륿ߥȥ󥹥ե顼ΦãǣԣС	gGTP (g-glutamyl transferase)
C12Q   1/48  Z	1	0	4B063	C12Q   1/48	2864	¾㡥ʡʥॿݥʤʬž̹ǣãѣ	Others ( kinase, cf. mutase (enzymes displaced inside molecules) R 1/533)
C12Q   1/50  \	2	2	4B063	C12Q   1/50	125	쥢ۥۥʡޤΡΣ	involving creatine phosphokinase [3]
C12Q   1/52  \	2	2	4B063	C12Q   1/52	204	ȥ󥹥ߥʡޤΡΣ	involving transaminase [3]
C12Q   1/527  \	1	1	4B063	C12Q   1/527	355	ղùǤޤΡΣ	involving lyase [5]
C12Q   1/533  \	1	1	4B063	C12Q   1/533	174	ǤޤΡΣ	involving isomerase [5]
C12Q   1/54  \	1	1	4B063	C12Q   1/54	629	륳ޤϥ饯ȡޤΡΣ	involving glucose or galactose [3]
C12Q   1/56  \	1	1	4B063	C12Q   1/56	405	ŷҤޤΡ㡥ȥӥ󡤥ȥܥץ饹󡤥ե֥ΥޤΡΣ	involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen [3]
C12Q   1/58  \	1	1	4B063	C12Q   1/58	163	ǢǤޤϥ쥢ޤΡΣ	involving urea or urease [3]
C12Q   1/60  \	1	1	4B063	C12Q   1/60	410	쥹ƥޤΡΣ	involving cholesterol [3]
C12Q   1/61  \	1	1	4B063	C12Q   1/61	135	ȥꥰꥻɤޤΡΣ	involving triglycerides [5]
C12Q   1/62  \	1	1	4B063	C12Q   1/62	89	ǢޤΡΣ	involving uric acid [3]
C12Q   1/64  \	1	1	4B063	C12Q   1/64	12	ϵʪŪ㡥ФΡΣ	Geomicrobiological testing, e.g. for petroleum [3]
C12Q   1/66  \	1	1	4B063	C12Q   1/66	1055	륷ե顼ޤΡΣ	involving luciferase [3]
C12Q   1/68  \	1	1	4B063	C12Q   1/68	5169	˻ޤΡΣ	involving nucleic acids [2018.01]
C12Q   1/68 100 \	2	2	4B063	C12Q   1/68	1	ߡƣɣãѣäꤹ뤿ΥߡƣɡڿͿߡ	Dummy fI C12Q1/68, dummy fI for setting up 100@C[stop new assigment]
C12Q   1/68 100 C	2	0	4B063	C12Q   1/68	743	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/68 is assigned [stop new assigment]
C12Q   1/68 100 Z	2	0	4B063	C12Q   1/68	315	¾	Others
C12Q   1/6804  \	2	2	4B063	C12Q   1/6804	6	ȱָѤ˻ʬϡȱʬϣǣΣˡΣ	Nucleic acid analysis using immunogens (immunoassay G01N33/53) [2018.01]
C12Q   1/6804  C	2	0	4B063	C12Q   1/6804	242	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6804 is assigned [stop new assigment]
C12Q   1/6804  Z	2	0	4B063	C12Q   1/6804	372	¾	Others
C12Q   1/6806  \	2	2	4B063	C12Q   1/6806	56	ʬѡ㡥Уãҥåѡγ˻ĴʣãѣͥˡΣ	Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) [2018.01]
C12Q   1/6806  C	2	0	4B063	C12Q   1/6806	843	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6806 is assigned [stop new assigment]
C12Q   1/6806  Z	2	0	4B063	C12Q   1/6806	2086	¾	Others
C12Q   1/6809  \	2	2	4B063	C12Q   1/6809	14	ǥե󥷥Ϥޤ˻ȽޤƱˡΣ	Methods for determination or identification of nucleic acids involving differential detection [2018.01]
C12Q   1/6809  C	2	0	4B063	C12Q   1/6809	495	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6809 is assigned [stop new assigment]
C12Q   1/6809  Z	2	0	4B063	C12Q   1/6809	908	¾	Others
C12Q   1/6811  \	2	2	4B063	C12Q   1/6811	13	ɸŪðŪʥꥴ̥쥪ɤޤϷʬҤκޤ߷פΤȴˡΣ	Selection methods for production or design of target specific oligonucleotides or binding molecules [2018.01]
C12Q   1/6811  C	2	0	4B063	C12Q   1/6811	227	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6811 is assigned [stop new assigment]
C12Q   1/6811  Z	2	0	4B063	C12Q   1/6811	411	¾	Others
C12Q   1/6813  \	2	2	4B063	C12Q   1/6813	25	ϥ֥󥢥åΣ	Hybridisation assays [2018.01]
C12Q   1/6813  C	2	0	4B063	C12Q   1/6813	426	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6813 is assigned [stop new assigment]
C12Q   1/6813  Z	2	0	4B063	C12Q   1/6813	2347	¾	Others
C12Q   1/6816  \	3	3	4B063	C12Q   1/6816	9	мʤˤħդΡʣãѣͥˡΣ	characterised by the detection means (C12Q1/6804 takes precedence) [2018.01]
C12Q   1/6816  C	3	0	4B063	C12Q   1/6816	646	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6816 is assigned [stop new assigment]
C12Q   1/6816  Z	3	0	4B063	C12Q   1/6816	1249	¾	Others
C12Q   1/6818  \	4	4	4B063	C12Q   1/6818	0	ʤȤ⣲ĤΥ٥ߺѤޤΡ㡥ĥͥ륮ưΣ	involving interaction of two or more labels, e.g. resonant energy transfer [2018.01]
C12Q   1/6818  C	4	0	4B063	C12Q   1/6818	339	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6818 is assigned [stop new assigment]
C12Q   1/6818  Z	4	0	4B063	C12Q   1/6818	490	¾	Others
C12Q   1/682  \	4	4	4B063	C12Q   1/682	3	ʥΣ	Signal amplification [2018.01]
C12Q   1/682  C	4	0	4B063	C12Q   1/682	217	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/682 is assigned [stop new assigment]
C12Q   1/682  Z	4	0	4B063	C12Q   1/682	287	¾	Others
C12Q   1/6823  \	4	4	4B063	C12Q   1/6823	0	ɸСΣ	Release of bound markers [2018.01]
C12Q   1/6823  C	4	0	4B063	C12Q   1/6823	212	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6823 is assigned [stop new assigment]
C12Q   1/6823  Z	4	0	4B063	C12Q   1/6823	281	¾	Others
C12Q   1/6825  \	4	4	4B063	C12Q   1/6825	6	󥵡ޤ˻СΣ	Nucleic acid detection involving sensors [2018.01]
C12Q   1/6825  C	4	0	4B063	C12Q   1/6825	298	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6825 is assigned [stop new assigment]
C12Q   1/6825  Z	4	0	4B063	C12Q   1/6825	440	¾	Others
C12Q   1/6827  \	3	3	4B063	C12Q   1/6827	38	Ѱۤޤ¿򸡽Ф뤿ΤΡΣ	for detection of mutation or polymorphism [2018.01]
C12Q   1/6827  C	3	0	4B063	C12Q   1/6827	904	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6827 is assigned [stop new assigment]
C12Q   1/6827  Z	3	0	4B063	C12Q   1/6827	2224	¾	Others
C12Q   1/683  \	4	4	4B063	C12Q   1/683	4	¹ǤޤΡ㡥¹Ĺ¿Σңƣ̣СϡΣ	involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP] [2018.01]
C12Q   1/683  C	4	0	4B063	C12Q   1/683	191	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/683 is assigned [stop new assigment]
C12Q   1/683  Z	4	0	4B063	C12Q   1/683	279	¾	Others
C12Q   1/6832  \	3	3	4B063	C12Q   1/6832	2	ϥ֥ȿ¥ʡΣ	Enhancement of hybridisation reaction [2018.01]
C12Q   1/6832  C	3	0	4B063	C12Q   1/6832	189	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6832 is assigned [stop new assigment]
C12Q   1/6832  Z	3	0	4B063	C12Q   1/6832	234	¾	Others
C12Q   1/6834  \	3	3	4B063	C12Q   1/6834	3	˻θؤιŪޤŪʷΣ	Enzymatic or biochemical coupling of nucleic acids to a solid phase [2018.01]
C12Q   1/6834  C	3	0	4B063	C12Q   1/6834	461	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6834 is assigned [stop new assigment]
C12Q   1/6834  Z	3	0	4B063	C12Q   1/6834	729	¾	Others
C12Q   1/6837  \	4	4	4B063	C12Q   1/6837	19	ץ֥쥤ޤϥץ֥åפѤΡʣãѣͥˡΣ	using probe arrays or probe chips (C12Q1/6874 takes precedence) [2018.01]
C12Q   1/6837  C	4	0	4B063	C12Q   1/6837	850	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6837 is assigned [stop new assigment]
C12Q   1/6837  Z	4	0	4B063	C12Q   1/6837	2218	¾	Others
C12Q   1/6839  \	3	3	4B063	C12Q   1/6839	0	ϥ֥󥢥åˤ뻰Ť餻ޤ¾Τ⼡Ωι¤ηΣ	Triple helix formation or other higher order conformations in hybridisation assays [2018.01]
C12Q   1/6839  C	3	0	4B063	C12Q   1/6839	60	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6839 is assigned [stop new assigment]
C12Q   1/6839  Z	3	0	4B063	C12Q   1/6839	107	¾	Others
C12Q   1/6841  \	3	3	4B063	C12Q   1/6841	9	ϥ֥Σ	In situ hybridisation [2018.01]
C12Q   1/6841  C	3	0	4B063	C12Q   1/6841	294	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6841 is assigned [stop new assigment]
C12Q   1/6841  Z	3	0	4B063	C12Q   1/6841	692	¾	Others
C12Q   1/6844  \	2	2	4B063	C12Q   1/6844	41	˻ȿΣ	Nucleic acid amplification reactions [2018.01]
C12Q   1/6844  C	2	0	4B063	C12Q   1/6844	530	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6844 is assigned [stop new assigment]
C12Q   1/6844  Z	2	0	4B063	C12Q   1/6844	2617	¾	Others
C12Q   1/6848  \	3	3	4B063	C12Q   1/6848	1	󥿥ߥ͡ɻ߼ʤޤȿð⤷ϴ٤夵ʤˤħդΡΣ	characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction [2018.01]
C12Q   1/6848  C	3	0	4B063	C12Q   1/6848	279	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6848 is assigned [stop new assigment]
C12Q   1/6848  Z	3	0	4B063	C12Q   1/6848	494	¾	Others
C12Q   1/6851  \	3	3	4B063	C12Q   1/6851	51	ŪΣ	Quantitative amplification [2018.01]
C12Q   1/6851  C	3	0	4B063	C12Q   1/6851	365	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6851 is assigned [stop new assigment]
C12Q   1/6851  Z	3	0	4B063	C12Q   1/6851	3226	¾	Others
C12Q   1/6853  \	3	3	4B063	C12Q   1/6853	12	ץ饤ޡޤϽ򷿤ѤΡΣ	using modified primers or templates [2018.01]
C12Q   1/6853  C	3	0	4B063	C12Q   1/6853	308	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6853 is assigned [stop new assigment]
C12Q   1/6853  Z	3	0	4B063	C12Q   1/6853	510	¾	Others
C12Q   1/6855  \	4	4	4B063	C12Q   1/6855	3	ץϢ뤹ΡΣ	Ligating adaptors [2018.01]
C12Q   1/6855  C	4	0	4B063	C12Q   1/6855	123	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6855 is assigned [stop new assigment]
C12Q   1/6855  Z	4	0	4B063	C12Q   1/6855	286	¾	Others
C12Q   1/6858  \	3	3	4B063	C12Q   1/6858	3	ΩҤðŪΣ	Allele-specific amplification [2018.01]
C12Q   1/6858  C	3	0	4B063	C12Q   1/6858	442	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6858 is assigned [stop new assigment]
C12Q   1/6858  Z	3	0	4B063	C12Q   1/6858	629	¾	Others
C12Q   1/686  \	3	3	4B063	C12Q   1/686	89	ݥ顼ϢȿΣУãҡϡΣ	Polymerase chain reaction [PCR] [2018.01]
C12Q   1/686  C	3	0	4B063	C12Q   1/686	938	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/686 is assigned [stop new assigment]
C12Q   1/686  Z	3	0	4B063	C12Q   1/686	7710	¾	Others
C12Q   1/6862  \	3	3	4B063	C12Q   1/6862	1	ꥬϢȿΣ̣ãҡϡΣ	Ligase chain reaction [LCR] [2018.01]
C12Q   1/6862  C	3	0	4B063	C12Q   1/6862	108	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6862 is assigned [stop new assigment]
C12Q   1/6862  Z	3	0	4B063	C12Q   1/6862	203	¾	Others
C12Q   1/6865  \	3	3	4B063	C12Q   1/6865	2	ץ⡼˴Ť㡥˻˴ŤΣΣӣ£ϡȻ³ʣˡΣӣҡϤޤžˡΣԣӡϡΣ	Promoter-based amplification, e.g. nucleic acid sequence-based amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS] [2018.01]
C12Q   1/6865  C	3	0	4B063	C12Q   1/6865	173	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6865 is assigned [stop new assigment]
C12Q   1/6865  Z	3	0	4B063	C12Q   1/6865	272	¾	Others
C12Q   1/6867  \	3	3	4B063	C12Q   1/6867	0	ץꥫ˴Ť㡥ѡݦ¡ݥץꥫѤΡΣ	Replicase-based amplification, e.g. using Q-beta replicase [2018.01]
C12Q   1/6867  C	3	0	4B063	C12Q   1/6867	39	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6867 is assigned [stop new assigment]
C12Q   1/6867  Z	3	0	4B063	C12Q   1/6867	73	¾	Others
C12Q   1/6869  \	2	2	4B063	C12Q   1/6869	54	ˡΣ	Methods for sequencing [2018.01]
C12Q   1/6869  C	2	0	4B063	C12Q   1/6869	742	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6869 is assigned [stop new assigment]
C12Q   1/6869  Z	2	0	4B063	C12Q   1/6869	5156	¾	Others
C12Q   1/6872  \	3	3	4B063	C12Q   1/6872	5	ʬˡޤΡΣ	involving mass spectrometry [2018.01]
C12Q   1/6872  C	3	0	4B063	C12Q   1/6872	67	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6872 is assigned [stop new assigment]
C12Q   1/6872  Z	3	0	4B063	C12Q   1/6872	157	¾	Others
C12Q   1/6874  \	3	3	4B063	C12Q   1/6874	14	˻쥤ޤΡ㡥ϥ֥ˤΣӣ£ȡϡΣ	involving nucleic acid arrays, e.g. sequencing by hybridisation [SBH] [2018.01]
C12Q   1/6874  C	3	0	4B063	C12Q   1/6874	328	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6874 is assigned [stop new assigment]
C12Q   1/6874  Z	3	0	4B063	C12Q   1/6874	882	¾	Others
C12Q   1/6876  \	2	2	4B063	C12Q   1/6876	75	˻ʬϤǻѤ˻ʪ㡥ץ饤ޡޤϥץ֡Σ	Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes [2018.01]
C12Q   1/6876  C	2	0	4B063	C12Q   1/6876	808	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6876 is assigned [stop new assigment]
C12Q   1/6876  Z	2	0	4B063	C12Q   1/6876	3825	¾	Others
C12Q   1/6879  \	3	3	4B063	C12Q   1/6879	2	ȽѡΣ	for sex determination [2018.01]
C12Q   1/6879  C	3	0	4B063	C12Q   1/6879	41	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6879 is assigned [stop new assigment]
C12Q   1/6879  Z	3	0	4B063	C12Q   1/6879	58	¾	Others
C12Q   1/6881  \	3	3	4B063	C12Q   1/6881	15	ȿޤϺ˦ʬѡ㡥ҥ平Σȣ̣ϥץ֡Σ	for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes [2018.01]
C12Q   1/6881  C	3	0	4B063	C12Q   1/6881	364	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6881 is assigned [stop new assigment]
C12Q   1/6881  Z	3	0	4B063	C12Q   1/6881	634	¾	Others
C12Q   1/6883  \	3	3	4B063	C12Q   1/6883	24	ʪѲ򸶰ȤµѡΣ	for diseases caused by alterations of genetic material [2018.01]
C12Q   1/6883  C	3	0	4B063	C12Q   1/6883	2675	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6883 is assigned [stop new assigment]
C12Q   1/6883  Z	3	0	4B063	C12Q   1/6883	3768	¾	Others
C12Q   1/6886  \	4	4	4B063	C12Q   1/6886	39	ѡʴѤȱʬϣǣΣˡΣ	for cancer (immunoassay for cancer G01N0033575000)[2018.01]
C12Q   1/6886  C	4	0	4B063	C12Q   1/6886	3021	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6886 is assigned [stop new assigment]
C12Q   1/6886  Z	4	0	4B063	C12Q   1/6886	4514	¾	Others
C12Q   1/6888  \	3	3	4B063	C12Q   1/6888	4	ʪθФޤƱѡΣ	for detection or identification of organisms [2018.01]
C12Q   1/6888  C	3	0	4B063	C12Q   1/6888	219	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6888 is assigned [stop new assigment]
C12Q   1/6888  Z	3	0	4B063	C12Q   1/6888	1122	¾	Others
C12Q   1/689  \	4	4	4B063	C12Q   1/689	10	ٶѡΣ	for bacteria [2018.01]
C12Q   1/689  C	4	0	4B063	C12Q   1/689	1021	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/689 is assigned [stop new assigment]
C12Q   1/689  Z	4	0	4B063	C12Q   1/689	1829	¾	Others
C12Q   1/6893  \	4	4	4B063	C12Q   1/6893	0	ưʪѡΣ	for protozoa [2018.01]
C12Q   1/6893  C	4	0	4B063	C12Q   1/6893	54	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6893 is assigned [stop new assigment]
C12Q   1/6893  Z	4	0	4B063	C12Q   1/6893	83	¾	Others
C12Q   1/6895  \	4	4	4B063	C12Q   1/6895	3	ʪࡤѡΣ	for plants, fungi or algae [2018.01]
C12Q   1/6895  C	4	0	4B063	C12Q   1/6895	431	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6895 is assigned [stop new assigment]
C12Q   1/6895  Z	4	0	4B063	C12Q   1/6895	938	¾	Others
C12Q   1/6897  \	2	2	4B063	C12Q   1/6897	24	ץ⡼˺ưǽϢ뤷ݡҤޤΡΣ	involving reporter genes operably linked to promoters [2018.01]
C12Q   1/6897  C	2	0	4B063	C12Q   1/6897	556	ѥƥȥեߥ꡼ˣãѣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12Q1/6897 is assigned [stop new assigment]
C12Q   1/6897  Z	2	0	4B063	C12Q   1/6897	1235	¾	Others
C12Q   1/70  \	1	1	4B063	C12Q   1/70	1960	륹ޤϥХƥꥪեޤΡΣ	involving virus or bacteriophage [3]
C12Q   3/00  \	0	0	4B063	C12Q   3/00	98	֤˱ˡʤΤ֣ãͣˡΣ	Condition-responsive control processes (apparatus therefor C12M 1/36) [3]
